Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

NCT03997981 is registered in ClinicalTrials.gov with Disarm Therapeutics as lead sponsor.

NCT NCT03997981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)
Lead sponsor
Disarm Therapeutics
Phase
Observational
Overall status
Unknown status
Start date
July 3, 2019
Completion date
April 9, 2024
Enrollment
200 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy